Zydus Lifesciences Receives FinalUsfda Approval For Pemetrexed AChemotherapy Drug
Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. It Is A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells.Zydus Lifesciences Ltd. Has Received Final Approval From The United States Food And Drug Administration (Us Fda) To Market Pemetrexed A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells In The Strengths Of 100 Mg Vial, 500 Mg Vial, And 1000 Mg Vial Singledose Vials (Usrld: Alimta). Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. The Drug Will Be Manufactured At Zydus Hospira. As Per Iqvia Mat March'22), Pemetrexed For Injection Has A Market Size Of $ 1,236 Mn The Group Now Has 314 Approvals And Has So Far Filed Over 400 Andas Since The Commencement Of The Filing Process In Fy 2003-04.
Let’s apply Data-Driven Pricing to Your APIs
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions!
Learn More!